945376-95-4 Usage
Uses
Used in Pharmaceutical Industry:
P-1004 (in stock) is used as an intermediate in the production of pharmaceuticals for its key role in the synthesis of various organic compounds. Its high purity and quality make it a reliable component in the development of new drugs and medications.
Used in Chemical Industry:
P-1004 (in stock) is used as a building block in the synthesis of dyes and other specialty chemicals due to its versatility and compatibility with a wide range of solvents. This allows for the creation of a diverse range of products with specific properties and applications.
Used in Research and Development:
P-1004 (in stock) is utilized in research and development as a starting material for the exploration of new chemical reactions and the creation of novel compounds. Its stability and compatibility with various solvents make it an ideal candidate for experimental work in the lab.
Check Digit Verification of cas no
The CAS Registry Mumber 945376-95-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,5,3,7 and 6 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 945376-95:
(8*9)+(7*4)+(6*5)+(5*3)+(4*7)+(3*6)+(2*9)+(1*5)=214
214 % 10 = 4
So 945376-95-4 is a valid CAS Registry Number.
945376-95-4Relevant academic research and scientific papers
BMP INHIBITORS AND METHODS OF USE THEREOF
-
Page/Page column 95, (2014/10/15)
The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds may also be used to reduce circulating levels of ApoB-100 or LDL and treat or prevent acquired or congenital hypercholesterolemia or hyperlipoproteinemia; diseases, disorders, or syndromes associated with defects in lipid absorption or metabolism; or diseases, disorders, or syndromes caused by hyperlipidemia.
TREATMENT OF ALZHEIMER'S DISEASE AND RELATED CONDITIONS
-
Page/Page column 17-18, (2010/11/28)
Compounds of formula (I) inhibit microtubule affinity regulating kinase (MARK), and hence are suitable for treating diseases associated with abnormal phosphorylation of tau.
